कृपया अन्य खोज का प्रयास करें
चिन्ह | एक्सचेंज | करेंसी | ||
---|---|---|---|---|
ALPN | NASDAQ | USD | रियल टाइम | |
34LA | ट्रेडगेट | EUR | देरी | |
34LA | फ़्रंकफ़र्ट | EUR | देरी |
Alpine Immune Sciences, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of immunotherapies through protein engineering technologies for treating autoimmune and inflammatory diseases. The company’s product pipeline includes Povetacicept, a dual B cell cytokine antagonist, which is in Phase 2 clinical trial for the treatment of multiple autoimmune and inflammatory diseases; and Acazicolcept, a dual inhibitor of the CD28 and ICOS T cell costimulatory pathways that is in preclinical trial for the treatment of systemic lupus erythematosus. It is also developing RUBY-3 that has completed Phase 1 clinical trial for the treatment of glomerulonephritis; and RUBY-4, which has completed Phase 1 clinical trial for the treatment of cytopenias. The company was incorporated in 2007 and is headquartered in Seattle, Washington.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Peter A. Thompson | 61 | 2016 | Independent Director |
Andrew M. Scharenberg | - | - | Scientific Advisory Board Chairman |
Robert E. Conway | 67 | 2017 | Independent Director |
Mitchell H. Gold | 53 | 2015 | Executive Chairman & CEO |
James N. Topper | 59 | 2016 | Independent Director |
Paul Tumeh | - | - | Member of Scientific Advisory Board |
Manish J. Butte | - | - | Member of Scientific Advisory Board |
Xiangmin Cui | 55 | 2019 | Independent Director |
John A. Thompson | - | 2018 | Member of Scientific Advisory Board |
Anne Davidson | - | - | Member of Scientific Advisory Board |
Christopher Peetz | 44 | 2018 | Independent Director |
Vijay Kumar Kuchroo | 68 | 2019 | Member of Scientific Advisory Board |
James Welsh | - | 2018 | Member of Scientific Advisory Board |
Rafi Ahmed | - | 2018 | Member of Scientific Advisory Board |
Natasha A. Hernday | 51 | 2020 | Independent Director |
Jorn Drappa | 58 | 2022 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है